Addressing sympathetic overactivity in major depressive disorder
Authors:
- Martin HausbergMHMartin Hausberg
- Uta HillebrandUHUta Hillebrand
- Klaus KistersKKKlaus Kisters
- 1 October 2007
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 25 (10) , 2004-2005
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?Journal Of Hypertension, 2007
- A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive DisorderThe Journal of Clinical Psychiatry, 2007
- Specific Serotonin Reuptake Inhibition in Major Depressive Disorder Adversely Affects Novel Markers of Cardiac RiskHypertension Research, 2007
- Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholiaProceedings of the National Academy of Sciences, 2005
- Relationship between major depression and heart rate variability.Psychiatry Research, 2002
- Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal DiseaseCirculation, 2002
- Heart period and QT variability, hostility, and type-A behavior in normal controls and patients with panic disorderJournal of Psychosomatic Research, 2000
- Cardiovascular death from panic disorder and panic-like anxiety: A critical review of the literatureJournal of Psychosomatic Research, 1998
- Major depression and cardiac autonomic controlBiological Psychiatry, 1997
- Adverse consequences of high sympathetic nervous activity in the failing human heartJACC, 1995